Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.

Novartis taps MOOC technology to share chemistry education with the world

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research

How two years in a Novartis lab changed Johnny Castillo’s life.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.